186 results on '"Forconi, Francesco"'
Search Results
2. Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL
3. Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial
4. The essential microenvironmental role of oligomannoses specifically inserted into the antigen-binding sites of lymphoma cells
5. BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
6. Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial
7. High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL
8. Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment
9. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells
10. Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL
11. Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study
12. DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity
13. Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia
14. Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter’s syndrome: therapeutic implications
15. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
16. Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL
17. IL-4 enhances expression and function of surface IgM in CLL cells
18. Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation
19. Perturbation of the normal immune system in patients with CLL
20. The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model
21. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features
22. Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK
23. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
24. Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function
25. S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis
26. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
27. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
28. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
29. The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma
30. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
31. The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity
32. Development of a distributed international patient data registry for hairy cell leukemia.
33. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
34. Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia
35. Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia
36. The normal IGHV1-69–derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL
37. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior
38. BCL2 Inhibition in Refractory Hairy-Cell Leukemia.
39. TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study.
40. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma
41. Overlapping morphologic and immunophenotypic profiles in small B-cell lymphoma. A report of two cases
42. Genome-wide high resolution DNA profiling of hairy cell leukaemia
43. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome
44. Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis
45. Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array
46. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience
47. Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia
48. A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction
49. BRAF Mutations in Hairy-Cell Leukemia
50. B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.